Py-1,2,3-triazole-benzyl (2). To a solution of 2-ethynylpyridine (1.18 mL,
11.68 mmol) and benzyl azide (1.55 g, 11.64 mmol) in 100 mL MeCN an
aqueous solution of CuSO4 (517 mg, 2.07 mmol) and sodium ascorbate
(2.77 g, 13.98 mmol) was added. The last two reagents were dissolved in a
minimum volume of water. A bright orange solid formed and the mixture
heated up. After addition of 15 mL of MeCN the solid dissolved over 5 h and
was left to stir at RT overnight. All solvents were removed under reduced
pressure, the orange solid was suspended in ethyl acetate and sonicated.
The suspension was filtered and the solvent was removed under reduced
pressure to yield an off-white solid. (1.51 g, 54%). 1H NMR (300 MHz,
acetone, d): 8.55 (ddd, J ¼ 4.8, 1.7, 0.9, 1H), 8.43 (s, 1H), 8.10 (dt, J ¼ 7.9,
1.0, 1H), 7.85 (td, J ¼ 7.7, 1.8, 1H), 7.48–7.32 (m, 5H), 7.28 (ddd, J ¼ 7.5,
4.8, 1.2, 1H), 2.81 (s, 2H).
Py-1,2,3-triazole-phenyl (3). Aniline (1.02 g, 11.0 mmol) was dissolved in
30 mL of dried and freshly distilled MeCN in a 100 mL round-bottomed
flask under N2 flow and cooled to 0 8C in an ice bath. Tert-butyronitrite
(1.74 g, 17 mmol) was added, followed by TMSN3 (1.31 g, 11.0 mmol). The
resulting solution was stirred at RT until thin-layer chromatography (TLC)
measurements showed no presence of aniline anymore. 2-Ethynylpyridine
(1.13 g, 11.0 mmol) was dissolved in the same round-bottomed flask for a
one-pot reaction. CuSO4ꢃH2O (206 mg, 0.8 mmol) and sodium ascorbate
(660 mg, 3.3 mmol) were added to the solution and the resulting mixture
was stirred at RT overnight. The solvent was evaporated under reduced
pressure and the product was diluted with dichloromethane, to be
extracted three times with 35% ammonia solution. The organic phases
were dried over MgSO4, the solvent was evaporated under reduced
pressure and the product purified by chromatography on silica gel and
dichloromethane/methanol (99:1) as eluent to achieve 7 (1.20 g, 49%). 1H
NMR (300 MHz, CDCl3, d): 8.69 (s, 1H), 8.60 (dq, J ¼ 6, 1H), 8.29 (dt, J ¼ 9,
1H), 7.82 (m, 3H), 7.56–7.32 (m, 5H). MS (ESI þ , MeOH, m/z): calcd.
222.25; found 223.09 [MþH]þ, 245.08 [M þ Na]þ.
to remove the excess of the sodium or ammonium salts, respectively. After
drying, the compounds were recrystallized from ethanol four times and
dried under vacuum afterwards.
(F2ppy)2 Ir Py-1,2,3-triaz-adamantyl BF4 (5a). 1H NMR (300 MHz,
CD2Cl2, d): 9.46 (s, 1H), 8.70 (d, J ¼ 8.2, 1H), 8.31 (d, J ¼ 8.5, 2H), 8.09
(d, J ¼ 6.3, 1H), 7.91–7.76 (m, 4H), 7.52 (dd, J ¼ 17.1, 6.2, 2H), 7.33
(d, J ¼ 6.2, 1H), 7.13–6.96 (m, 2H), 6.57 (d, J ¼ 18.0, 1H), 5.75 (t, J ¼ 9.9,
2H), 2.23 (s, 2H), 2.21 (s, 7H), 1.76 (s, 7H). 19F NMR (282 MHz, CD2Cl2,
d): ꢀ106.71 (d, J ¼ 10.9, 1H), ꢀ107.93 (d, J ¼ 10.4, 1H), ꢀ109.10
(d, J ¼ 10.9, 1H), ꢀ110.20 (d, J ¼ 10.4, 1H), ꢀ151.60–152.10 (m, 2H).
HRMS: [M]þ calcd. 809.1624, found 809.1587. Anal. calcd. for
C39H32BF8IrN6: C 49.85; H 3.43; N 8.94; found: C 49.82, H 3.47, N 8.84.
(F2ppy)2 Ir Py-1,2,3-triaz-adamantyl PF6 (5b). 1H NMR (300 MHz,
CD2Cl2, d): 8.78 (s, 1H), 8.31 (d, J ¼ 7.9, 3H), 8.08 (td, J ¼ 7.8, 1.6, 1H),
7.84 (dt, J ¼ 7.6, 5.6, 3H), 7.52 (ddd, J ¼ 17.1, 5.8, 0.8, 2H), 7.36 (ddd,
J ¼ 7.6, 5.5, 1.3, 1H), 7.06 (dddd, J ¼ 18.1, 7.3, 5.9, 1.4, 2H), 6.57 (dddd,
J ¼ 18.0, 12.5, 9.2, 2.3, 2H), 5.74 (ddd, J ¼ 10.6, 8.6, 2.4, 2H), 2.25 (s, 3H),
2.20 (d, J ¼ 2.7, 6H), 1.85–1.71 (m, 7H). 19F NMR (282 MHz, CD2Cl2, d):
ꢀ71.32 (s, 3H), ꢀ73.83 (s, 3H), ꢀ106.64 (dt, J ¼ 10.8, 9.0, 1H), ꢀ107.76–
107.96 (m, 1H), ꢀ108.94–109.14 (m, 1H), ꢀ110.15 (dd, J ¼ 17.9, 7.5, 1H).
Mass L1-53-01 MS (ESI þ , MeOH, m/z): [M]þ 853.2224. Anal. calcd. for
C
39H32F10IrN6P: C 46.94, H 3.23, N 8.42; found: C 46.26, H 3.27, N 8.01.
(F2ppy)2 Ir Py-1,2,3-triaz-benzyl BF4 (6a). 1H NMR (300 MHz, CD2Cl2,
d): 9.04 (s, 1H), 8.38–8.25 (m, 3H), 8.06 (tt, J ¼ 7.9, 3.8, 1H), 7.90–7.76 (m,
3H), 7.68–7.59 (m, 1H), 7.51–7.43 (m, 1H), 7.42–7.29 (m, 6H), 7.04
(dddd, J ¼ 17.0, 7.3, 5.9, 1.4, 2H), 6.58 (dddd, J ¼ 14.8, 12.5, 9.2, 2.4, 2H),
5.77 (ddd, J ¼ 14.6, 8.5, 2.3, 2H), 5.70–5.55 (m, 2H), 1.64 (s, 2H). 19F NMR
(282 MHz, CD2Cl2, d): ꢀ106.65 (dt, J ¼ 10.8, 9.0, 1H), ꢀ107.48 (dt,
J ¼ 10.4, 9.0, 1H), ꢀ108.90–109.14 (m, 1H), ꢀ109.71–109.94 (m, 1H),
ꢀ151.35–151.49 (m, 3H). MS (ESI þ , MeOH, m/z): [M]þ 809.1587.
HRMS [M]þ calcd. 809.1624; found: 809.1587. Anal. calcd for
C36H24BF8IrN6: C 48.28, H 2.70, N 9.38; found: C 47.90, H 2.74, N 9.31.
(F2ppy)2 Ir Py-1,2,3-triaz-benzyl PF6 (6b). 1H NMR (300 MHz, CD2Cl2,
d): 8.63 (s, 1H), 8.31 (d, J ¼ 7.0, 2H), 8.14 (d, J ¼ 7.5, 1H), 8.05 (td, J ¼ 7.8,
1.6, 1H), 7.84 (t, J ¼ 6.8, 3H), 7.63 (d, J ¼ 5.0, 1H), 7.46 (d, J ¼ 5.0, 1H),
7.43–7.28 (m, 6H), 7.13–6.97 (m, 2H), 6.67–6.51 (m, 2H), 5.81–5.71 (m,
2H), 5.61 (s, 2H), 1.19 (t, J ¼ 7.0, 2H). 19F NMR (282 MHz, CD2Cl2, d):
ꢀ71.39 (s, 3H), ꢀ73.90 (s, 3H), ꢀ106.59 (dt, J ¼ 10.9, 9.0, 1H), ꢀ107.28–
107.47 (m, 1H), ꢀ108.95 (t, J ¼ 11.7, 1H), ꢀ109.77 (t, J ¼ 11.5, 1H). MS
(ESI þ , MeOH, m/z): [M]þ 809.1612. HRMS [M]þ calcd. 809.1624; found:
809.1642. Anal. calcd. for C36H24F10IrN6P: C 45.33, H 2.54, N 8.81; found:
C 45.29, H 2.51, N 8.71.
(F2ppy)2 Ir Py-1,2,3-triaz-phenyl BF4 (7a). 1H NMR (300 MHz, CDCl3, d):
9.77 (s, 1H), 8.75 (d, J ¼ 9, 1H), 8.25 (d, J ¼ 9, 2H), 8.07 (td, J ¼ 9, 3, 1H),
7.84–7.66 (m, 6H), 7.47 (m, 4H), 7.30 (t, J ¼ 6; 1H), 7.08–6.98 (m, 2H),
6.56–6.43 (m, 2H), 5.65 (td, J ¼ 9, 1.5, 2H). MS (ESI þ , MeOH, m/z): [M]þ
calcd. 795.95; found: 795.15. Anal. calcd for C35H22F8IrN6B: C 47.68, H
2.52, N 9.53; found: C 45.85, H 2.59, N 8.94.
(F2ppy)2 Ir Py-1,2,3-triaz-phenyl PF6 (7b). 1H NMR (300 MHz, CDCl3, d):
9.77 (s, 1H), 8.75 (d, J ¼ 9, 1H), 8.25 (d, J ¼ 9, 2H), 8.07 (td, J ¼9, 3, 1H),
7.84–7.66 (m, 6H), 7.47 (m, 4H), 7.30 (t, J ¼ 6; 1H), 7.08–6.98 (m, 2H),
6.56–6.43 (m, 2H), 5.65 (td, J ¼ 9, 1.5, 2H). MS (ESIþ, MeOH, m/z): [M]þ
calcd. 795.95; found: 795.15. Anal. calcd. for C35H22F10IrN6P: C 44.73, H
2.36, N 8.94; found: C 40.26, H 2.57, N 8.27.
4-Azido-biphenyl. 4-Bromo-biphenyl (1.4 g, 6.01 mmol) and sodium
azide (773 mg, 11.9 mmol) in 100 mL ethanol/water 3:1 were degassed by
bubbling of nitrogen for 5 min. Copper(I) iodide (228 mg, 1.2 mmol),
sodium ascorbate (59 mg, 0.3 mmol), and N,N’-dimethyl ethylenediamine
(0.2 mL, 1.9 mmol) were added and nitrogen was bubbled for another
3 min. The reaction mixture was refluxed for 6 h and the reaction was
monitored via TLC. After the reaction was finished a white precipitate was
filtered off, washed with water and dried under vacuum. (920 mg, 78%). 1H
NMR (300 MHz, CDCl3, d): 2.37 (dd, J ¼ 10.6, 4.1, 4H), 2.23 (t, J ¼ 7.4, 2H),
2.13 (t, J ¼ 7.3, 1H), 1.89 (d, J ¼ 8.6, 2H).
Py-1,2,3-triazole-biphenyl (4). 4-Azido-biphenyl (720 mg, 3.4 mmol), 2-
ethynylpyridine (380 mg, 3.7 mmol), and tetrakis(acetonitrile)copper(I)
hexafluorophosphate (273 mg, 0.7 mmol) in dichloromethane/methanol
4:1 were stirred at RT for 14 h. The product started precipitating after 1.5 h,
was filtered off, washed with water, and dried under vacuum to yield a light-
yellow solid (500 mg, 50%). 1H NMR (300 MHz, CDCl3, d): 8.49 (ddd,
J ¼ 4.9, 1.7, 0.9, 1H), 8.16 (s, 1H), 8.12 (dt, J ¼ 8.0, 1.0, 1H), 7.69 (td,
J ¼ 7.8, 1.8, 1H), 7.20–7.06 (m, 1H), 2.21 (s, 10H), 1.70 (d, J ¼ 12.7, 7H).
General Procedure for the Preparation of Iridium(III) Complexes with
Chloride Counterions: The dimer (F2ppy)2Ir(m-Cl)2Ir(F2ppy)2 and the
according 1,2,3-triazole were stirred in dichloromethane/ethanol 5:1
overnight. The starting materials were solubilized within 45 min. The
solvents were removed under reduced pressure. The resulting yellow solids
were dissolved in acetonitrile and filtered through celite. The solvent was
removed under reduced pressure and the solid was recrystallized from
ethanol three times and dried under vacuum.
General Procedure for Ion Exchange on the Iridium(III) Complexes: The
chloride counterion was exchanged to the desired tetrafluoroborate a or
hexafluorophosphate b by stirring the compound in a dichloromethane/
methanol mixture (10:1) with sodium tetrafluorborate or ammonium
hexafluorophosphate, respectively. The according complex with chloride
counterion was dissolved in an excess of dichloromethane. Another
solution of 15 equivalents of either ammonium hexafluorophosphate or
sodium tetrafluoroborate in methanol was added and the resulting turbid
mixture was stirred for 18 h at RT. After the removal of the solvents the
crude reaction mixture was suspended in water and sonicated for 5 min.
The precipitate was filtered off and washed with water excessively in order
(F2ppy)2 Ir Py-1,2,3-triaz-biphenyl BF4 (8a). 1H NMR (300 MHz, CD2Cl2,
d): 9.65 (s, 1H), 8.67 (d, J ¼ 7.8, 1H), 8.34 (d, J ¼ 9.2, 2H), 8.15 (t, J ¼ 7.9,
1H), 7.97 (d, J ¼ 8.8, 2H), 7.92–7.77 (m, 6H), 7.64 (d, J ¼ 6.9, 2H), 7.55
(d, J ¼ 5.0, 1H), 7.44 (dt, J ¼ 22.2, 7.0, 4H), 7.15–7.02 (m, 2H), 6.62 (ddd,
J ¼ 24.5, 12.1, 6.9, 2H), 5.84–5.74 (m, 2H), 5.33 (s, 3H). 19F NMR
(282 MHz, CD2Cl2, d): ꢀ106.34–106.74 (m, 1H), ꢀ107.37–107.71 (m, 1H),
ꢀ108.96 (t, J ¼ 11.7, 1H), ꢀ109.84 (t, J ¼ 11.5, 1H), ꢀ151.10 (dd, J ¼ 2.3,
1.1, 4H). MS (ESI þ , MeOH, m/z): [M]þ 871.1777. HRMS calcd. [M]þ
871.1781; found 871.1777. Crystals were grown from CH2Cl2. Anal. calcd.
for C41H26BF8IrN6 þ CH2Cl2: C 48.38, H 2.71, N 8.06; found: C 48.25, H
2.78, N 7.95.
(F2ppy)2 Ir Py-1,2,3-triaz-biphenyl PF6 (8b). 1H NMR (300 MHz, CD2Cl2,
d): 9.28 (s, 1H), 8.45 (d, J ¼ 7.9, 1H), 8.33 (dd, J ¼ 8.4, 1.0, 2H), 8.13 (td,
J ¼ 7.8, 1.6, 1H), 7.97–7.72 (m, 8H), 7.67–7.59 (m, 2H), 7.55 (dd, J ¼ 5.9,
Adv. Funct. Mater. 2010, 20, 1812–1820
1818
ß 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim